Gerwyn Morris

TL;DR: An updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD indicates that antidepressants decrease several markers of peripheral inflammation, but does not provide evidence that reductions in peripheral inflammation are associated with antidepressant treatment response.

TL;DR: This review aims to describe the putative mechanisms by which surgery‐induced inflammation produces cognitive sequelae, with a focus on identifying potential novel therapies based upon their ability to modify these pathways.

TL;DR: Mechanisms by which elevated levels of reactive oxygen and nitrogen species together with elevated pro-inflammatory cytokines could conspire to pave a major road to the development of mitochondrial dysfunction and impaired oxidative metabolism seen in many patients diagnosed with these disorders are detailed.

TL;DR: A comprehensive review of the intertwined biobehavioral pathways linking depression to cancer progression is provided and behavioral strategies aiming at reducing psychological distress and depressive symptoms may represent important strategies to improve wider cancer-related outcomes.

TL;DR: The role of microbial metabolites in the pathophysiology of diabetes type 2 and autism is described and dysbiosis leading to reduced butyrate levels may increase bacterial translocation into the systemic circulation.